Chapter 23: Antidepressants & Mood Stabilizer Drugs

Welcome to Last Minute Lecture.

This free chapter overview is designed to help students review and understand key concepts.

These summaries supplement not replaced the original textbook and may not be redistributed or resold.

For complete coverage, always consult the official text.

Okay, let's unpack this.

We have a massive stack of notes on the desk today.

And honestly, if there is one topic in pharmacology that feels like a journey through the human condition itself, the highs, the lows, the stability we all crave,

it's got to be this one.

It's so true.

We are diving deep into chapter 23 of pharmacology, a patient centered nursing process approach,

the 12th edition.

It is a fascinating chapter.

I mean, it really sits right at the intersection of biology and emotion.

We are dealing with the chemistry of happiness, the physiology of despair, and you know, the biological mechanisms of stability.

It's dense, but it's incredibly human.

Exactly.

We are talking about antidepressants and mood stabilizers, and the mission for this deep dive is pretty specific.

We aren't just skimming the surface here.

No, not at all.

We are going to provide a comprehensive summary of this chapter.

We want to take these dense textbook concepts, the pharmacokinetics, the receptor sites, the safety alerts, you know, the boxed warnings, and translate them into something clear and accessible, specifically for nursing students or anyone trying to master this material.

Or really for anyone who wants to understand the why behind these medications.

Because as we'll see, it's not just about memorizing a list of drug names, it's about understanding the mechanisms so you can keep a patient safe.

The text emphasizes safety over and over and over again, and that's what we need to focus on.

So here is the roadmap for the next hour or so.

We are going to strictly follow the structure of chapter 23.

We'll start by understanding the pipes and pathophysiology of depression, what is actually happening in the brain when someone is depressed.

Then we're going to break down the five distinct groups of antidepressants, the tricyclics or TCAs, the SSRIs, the SNRIs, the atypicals, and the formidable MAOIs.

And we absolutely cannot forget the mood stabilizers.

We will be spending a significant amount of time on bipolar disorder and the gold standard treatment, lithium.

Oh, definitely.

That section alone is just packed with critical safety data that makes a difference between a therapeutic dose and, well, a toxic one.

And finally, because this is based on a nursing process text, we are going to wrap up with the critical stuff,

assessment interventions and patient teaching, the things that actually matter when you're at the bedside.

That's the goal, to bridge that gap between the chemical structure in the book and the human patient sitting right there in front of you.

So let's jump right in.

Section one, depression overview and pathophysiology.

The text starts with some heavy statistics that really set the stage for why this matters so much.

It really does.

It highlights that depression is the most common mental illness in the United States.

We are talking about approximately 14 .8 million Americans.

That is just a staggering number.

It is.

It's not some niche issue.

It is a pervasive public health crisis.

It really is.

And looking at the demographics provided, there's a distinct gender disparity here, which is interesting.

Yes.

The text notes that females between the ages of 25 and 45 are two to three times more likely than males to experience major depression.

Wow.

Two to three times.

Yeah.

That is a significant epidemiological signal.

It suggests there are likely hormonal, social or, you know, biological variances at play that make that specific demographic more vulnerable.

But what really jumped out at me was this idea of the treatment gap.

The source says fewer than 50 % of individuals with depression seek treatment.

That is just heartbreaking when you think about it.

It is, especially because the statistics also show that about 70 % of individuals have a full remission with effective treatment.

So the help is there.

The help is there.

So you have a condition that is highly treatable, yet half the people suffering aren't getting that help.

It just underscores the stigma and the barriers to care that still exist.

It's not that the drugs don't work.

It's that we can't get them to the people who need them.

And that leads us right into the clinical presentation.

We all think we know what depression looks like.

It's sadness, right?

Yep.

But the textbook breaks it down into very specific symptoms.

It is characterized primarily by mood changes and loss of interest in normal activities.

Which clinicians often call anhedonia.

Anhedonia, right.

But also, and this is what students often miss, physical symptoms.

Depression isn't just in your head, it's in your body.

That's a great point.

The text lists things like weight loss or gain,

insomnia, not being able to sleep, or hypersomnia, which is, you know, sleeping too much, loss of energy, fatigue, feelings of despair.

It affects the ability to think or concentrate.

It's a whole body shut down in many ways.

And the most critical symptom, the one that makes this a life or death situation, is the suicide risk.

Absolutely.

The text states that approximately 66 % of all suicides are related to depression.

That is the number one mortality risk associated with this diagnosis.

Two -thirds.

And here's a nuanced point the chapter makes regarding demographics.

While females are more likely to experience major depression, males, especially older white males, are more likely to commit suicide successfully.

That is a very sobering fact.

It really changes how you might assess risk in different patient populations.

It does.

And there is a specific warning in this chapter that I think every nursing student needs to like tattoo on their brain.

It's about antidepressants and suicidal ideation.

You would think treating depression lowers the risk immediately, but the text says it can actually mask it.

It's a paradox and it's a dangerous one.

Antidepressants can mask suicidal ideation or in some cases, and this is the really critical part, provide the patient with the physical energy to carry out a plan they previously didn't have the energy to execute.

Can you explain that a bit more?

That just seems so counterintuitive.

Okay, think about deep depression.

It often comes with something called psychomotor retardation.

You are physically slow, heavy, you feel like you can't get out of bed.

Right, like your body is made of lead.

Exactly.

Your mind might be full of dark thoughts, but your body is leaden.

When you start an antidepressant, specifically something like an SSRI or TCA,

the physical energy often returns before the mood lifts.

Oh, I see where this is certainly has the motor function and the energy to acts on that despair.

That creates a window of extremely high risk right at the start of treatment.

So that requires vigilant monitoring.

You can't just hand over a prescription and say, see it in a month.

Exactly.

The nursing vigilance is highest when the treatment begins.

You are watching for that sudden lift in energy without a corresponding lift in mood.

It's a huge red flag.

Okay, let's distinguish between the types of depression because the treatment varies depending on what we're dealing with.

The chapter lists three types, reactive, major, and bipolar.

Let's start with reactive depression.

The text describes this as having a sudden onset, usually triggered by a precipitating event, a loss, the death of a loved one, a major life change.

So this is what a patient might come in and call the blues.

Exactly.

The patient usually knows why they're depressed.

It's situational, typically last for months.

And interestingly, the text notes that for this specific type, a benzodiazepine agent might be prescribed rather than a full course of antidepressants, depending on the severity.

So you're treating the anxiety around the event, not necessarily a deep seated chemical imbalance.

Precisely.

It's often treated as a temporary state that needs support rather than a permanent chemical issue.

Then we have major depression.

This is deeper.

The book uses the word dysphoria, loss of interest in work and home, inability to concentrate.

This can be primary, meaning it's unrelated to other health problems, or it can be secondary to a health problem like a physical or psychiatric disorder or drug use.

But the key here is the severity and the duration.

It interferes with life.

Right.

It's debilitating.

And this is the core target for the antidepressant drugs we are about to discuss.

And the third type is bipolar disorder.

Previously, you know, referred to as manic depression.

This involves mood swings between two poles,

the manic state, which is euphoric, hyperactive, and sometimes delusional, and the depressive state, which is dysphoric.

And you treat this very differently.

Oh, completely differently.

If you give an antidepressant to someone in a bipolar cycle without a mood stabilizer, you might trigger mania.

You can push them right up to the other pole.

So lithium was originally the drug of choice here.

Now, other mood stabilizers like

carbamazepine, valproic acid, and lamatrigine are also currently first line drugs.

Okay.

Before we get to the drugs themselves, we have to talk about the monoamine theory.

This is the pathophysiology part.

What is actually happening in the brain?

Well, many theories exist, but the text focuses on the insufficiency theory.

It suggests an insufficient amount of brain monoamine

neurotransmitters,

specifically norepinephrine, serotonin,

and perhaps dopamine.

Okay.

Let's unpack those chemicals.

I feel like we hear these names all the time, but what do they actually do?

Serotonin is the heavy hitter.

It functions to regulate sleep, wakefulness, and mood.

It's your emotional regulator.

Interestingly, it's also involved in the delusions, hallucinations, and withdrawal you've seen schizophrenia.

It's a powerful chemical.

And norepinephrine.

That is associated with the control of arousal, attention, vigilance, mood, effect, and anxiety.

It's the thinking and planning and interpreting neurotransmitter.

You can think of it as the get up and go chemical.

Okay.

And dopamine is also mentioned for thinking and planning.

So, if these levels are low, depression sets in.

Therefore, the goal of therapy, the mission of these drugs is what?

To keep those chemicals active in the brain for longer.

The drugs aim to block the reuptake or the inactivation of these neurotransmitters.

I always like to visualize this.

Imagine the nerve ending releases the chemical into the gap, the synapse, to send a message to the next nerve.

And normally, there are these little vacuums that suck it back up to recycle it.

That's reuptake.

Right.

That vacuum is efficient.

It cleans up the message quickly.

But in a depressed brain, we think the signal is weak.

So, we want that message to stick around longer.

So, you're amplifying the signal.

Exactly.

If you block that vacuum, the chemical stays in the gap longer, hitting the receptor again and again.

It amplifies the signal.

That's what reuptake inhibitors do.

Or in the case of MAOIs, they stop the enzyme that literally eats the chemical.

Either way, you get more neurotransmitter activity.

Simple enough in theory, but as we'll see, very complex in practice.

Before we leave this overview, there is a specific warning about complementary and alternative therapies,

specifically St.

John's wort and ginkgo biloba.

This is so crucial for

St.

John's wort has been suggested for mild depression.

It's available over the counter.

Anyone can buy it.

Right.

People think it's natural.

It's safe.

But mechanically, St.

John's wort can decrease the reuptake of serotonin, norepinephrine, and dopamine.

It's essentially doing the exact same thing as the prescription drugs.

So, if you take St.

John's wort with a prescription SSRI, you risk serotonin syndrome, dizziness, headache, sweating, agitation.

It's a overload of serotonin because you are hitting the system from two different sides.

The text highlights this interaction specifically as a major danger.

And what about surgery?

The text explicitly says herbal products should be discontinued one to two weeks before surgery.

They can interact with anesthetics.

They can affect bleeding times.

A patient might not think to mention the tea or supplements they take to the surgeon because they think it's just natural.

So, the nurse has to ask.

That's a great clinical pearl.

Okay.

Let's move to section two.

The first group of antidepressants, the tricyclic antidepressants, or TCAs.

The old guard.

These were marketed way back in the late 1950s.

The text mentions they are effective and cheaper than newer drugs, but they seem to come with a lot of baggage.

First, how do they work?

They block the uptake of both norepinephrine and serotonin in the brain.

It's a broad action.

I like to think of them as a shotgun approach compared to the sniper rifle of the newer drugs.

A shotgun.

I like that.

They hit the targets they need to, but they hit a lot of other things too.

And that's where the problems start.

And there is a lag time, right?

You don't pop a pill and feel better an hour later.

No.

And managing that expectation is a key nursing implication.

The clinical response takes two to four weeks.

That's a long time to wait when you're suffering.

It is.

If there's no improvement after that window, the provider usually tapers them off and tries something else.

But patients need to know they won't feel better overnight.

This is often where compliance fails.

Patients think the drug isn't working, and they stop taking it just before it might have kicked in.

Let's talk about the specific drugs in this class.

Amitriptyline, imipramine, doxpin, nortriptyline.

The text highlights a few specific use cases that are pretty interesting.

Yes.

Imipranhydrochloride is highlighted for the treatment of enuresis that's bedwetting in children.

That seems so random for an antidepressant.

Why would a mood drug stop bedwetting?

It relates directly to the side effects we'll discuss in a moment, specifically urinary retention.

Key CAs tighten the bladder sphincter.

So in this case, we are actually using a side effect as the primary therapeutic effect.

It helps the child hold their urine through the night.

That is clever pharmacology, turning a bug into a feature.

Exactly.

And amitriptyline and doxpin.

They have high sedative effects.

So if a patient is agitated and depressed, what you might call anxious depression, these are useful because they calm the patient down.

They are almost always dosed at night to use that sedation to help a sleep problem.

Okay, but let's talk about why these aren't the first choice anymore.

The side effects.

I call these the side effect heavyweights.

It's a fair nickname.

Key CAs are not subtle.

First, you have sedation, which is caused by a histamine blockade.

Then you have orthostatic hypotension.

And this is a major safety risk, especially for the elderly.

DCAs block alpha -adrenergic receptors.

This affects the body's ability to regulate blood pressure when changing position.

So you stand up too fast and you get dizzy.

You get dizzy, lightheaded, you could fall.

Patient teaching is vital here.

Rise slowly.

Sit on the edge of the bed for a minute before standing up.

Let your blood pressure catch up.

Then we have the anticholinergic effects.

This is a classic nursing school list.

It is.

TCA's block cholinergic receptors.

Acetylcholine is the wet neurotransmitter.

In case you salivate, urinate, digest, when you block it, you dry everything up.

Can't see, can't pee, can't spit.

You can't.

Well, the fourth one is constipation.

So yeah, dry mouth, urinary retention, constipation, blurred vision.

And it speeds the heart up, tachycardia.

But the most serious adverse reaction listed in the text?

Cardiotoxicity.

High doses can cause dysrhythmias.

This is why an overdose on TCA's is so dangerous and potentially fatal.

It disrupts the electrical conduction of the heart.

And it also mentions blood dyscrasias.

Yeah, leukopenia, thrombocytopenia.

You need to monitor blood counts.

It can suppress the bone marrow in some patients.

The drug interactions seem scary too.

They are.

Alcohol, hypnotics, sedatives, barbiturates.

They all potentiate the CNS depression.

Meaning they can stop your breathing if they're combined.

It's a synergistic effect.

Can you mention MAOIs?

You absolutely cannot mix TCA's with MAOIs.

Or you risk cardiovascular instability and toxic psychosis.

It's an incredibly volatile combination.

Okay, so TCA's.

Effective, cheap, but heavy on side effects and risky for the heart.

Let's move to the modern era.

Section three.

Selective serotonin reuptake inhibitors or SSRIs.

These are the popular ones.

Phloxetine, sertraline, proxetine, acetylopram, acetylopram.

You see these on patient charts everywhere.

And why are they so popular?

Precision.

Remember the shotgun analogy for TCA's.

Right.

SSRIs are the laser.

They selectively block the reuptake of serotonin only.

They do not block uptake of dopamine or norepinephrine.

And critically, they do not block cholinergic and alpha -adrenergic receptors.

So that means no dry mouth, no dizziness.

Exactly.

Fewer side effects.

No sedation.

No hypotension.

No anti -cholinergic effects like dry mouth or urinary retention.

And most importantly, no cardio toxicity.

That is a massive upgrade in terms of the safety profile.

It is.

It's why they are the first line of treatment now.

They're much harder to overdose on and much easier for patients to live with day to day.

So what are they primarily used for?

Major depressive disorders, obviously.

But the text also lists anxiety disorders, OCD, panic disorders,

phobias, PTSD,

even prevention of migraines and minimizing aggressive behavior in borderline personality disorder.

Wow.

That's a wide range.

It is.

Because serotonin regulates so much of our emotional stability, these drugs are incredibly versatile.

Let's zoom in on the prototype drug mentioned, fluoxetine, better known as Prozac.

The text gives us a lot of detail here.

Yes.

The pharmacokinetics are really important for fluoxetine.

It is strongly protein bound and it has a very long half -life.

We're talking four to six days.

What does that mean for the patient in practical terms?

It means it has a cumulative effect.

It builds up in your system.

And if you stop taking it, it stays in your system for a long time.

It watches out very slowly.

There is actually a weekly delayed release dose available, 90 milligram.

But the text notes you have to stabilize the patient on the daily dose first.

It's not all sunshine though, right?

SSRIs do have adverse effects.

And there's one big one that causes a lot of non -compliance.

Sexual dysfunction.

The text is very explicit about this.

Decrease in sexual arousal, erectile dysfunction, delayed ejaculation.

For many patients, this is a deal breaker.

I can imagine.

They feel better emotionally, but the impact on their relationships or their self -image is just too high and it's a common reason they stop taking the meds.

Nurses need to ask about this specifically because patients are often too embarrassed to volunteer the information.

It also mentions dry mouth, insomnia, headache.

And again, suicidal ideation is still a risk, especially early on.

That doesn't go away.

Correct.

And there's a dietary interaction here too.

Grapefruit juice.

The nemesis of pharmacology.

Why does grapefruit juice hate so many medications?

It inhibits the CYP450 enzyme system in the liver.

Basically, it stops the liver from breaking down the drug as it should.

With SSRIs, this can lead to toxicity because the drug levels spiked higher than intended.

So what's the recommendation?

The book says to limit intake to eight ounces daily or half a fruit.

Just be mindful of it.

Okay, moving on to section four.

The SNRIs and atypical antidepressants.

Let's start with SNRIs.

Serotonin or a panophrine reuptake inhibitors.

Think of these as a middle ground.

They inhibit the reuptake of both serotonin and norepinephrine, like the TCAs.

But without all the other messy receptor blocking.

Exactly.

They're cleaner than TCAs but broader than SSRIs.

So drugs like venlafaxine, deloxetine, desmenlafaxine.

Right.

And they're used for major depression,

generalized anxiety disorder, or GAD, and social anxiety.

But because they bring norepinephrine back into the mix, you start to see some of those adrenergic side effects again, like hypertension and tachycardia.

Because norepinephrine is a stress hormone, essentially.

That's right.

So increasing it can stretch the cardiovascular system.

And the text notes some serious, though rare risks, like seizures and Stevens -Johnson syndrome.

Then we have the atypical or second generation antidepressants.

This is kind of the miscellaneous category.

They affect one or two of the three neurotransmitters, serotonin, norepinephrine, dopamine, and various combinations.

They are the mix and match group.

The text mentions amoxapine and naprotein.

Naprotein is chemically similar to the TCAs.

And the big warning here is, do not use with MAOIs.

You need a 14 -day washout period.

That means if you stop an MAOI, you must wait two full weeks before starting naprotein or vice versa.

The risk is too high.

And bupropion.

That's an amino ketone.

It's pretty unique.

It's used for depression, but also famously for smoking cessation under the brand name Zybun.

Oh, great.

It affects dopamine more than the others.

However, and this is a big one, the text notes that it lowers the seizure threshold.

So you have to be very careful with patients who have a history of seizures, eating disorders, or head trauma.

OK.

We have arrived at the scary part of the chapter.

Section five.

Monoamine oxidase inhibitors, or MAOIs.

The last resort.

Why are they the last resort?

Because while they are as effective as TCAs, the risk of adverse reactions, specifically fatal drug food interactions,

is incredibly high.

Only about 1 % of patients on antidepressants take these.

They're usually for patients who have failed every other treatment option.

Let's explain the mechanism.

MAO is an enzyme.

Yes.

Monoamine oxidase.

Think of it as the janitor of the brain's synapses.

This enzyme normally inactivates norepinephrine, dopamine, epinephrine, and serotonin.

It cleans them up after they've done their job.

So MAOIs inhibit this enzyme.

They stop the janitor from working.

And as a result, levels of all those neurotransmitters rise.

That sounds great for depression, but terrible for blood pressure regulation.

Exactly.

And this leads us to the infamous cheese effect.

This is famous.

Tell us about the cheese effect.

It sounds kind of funny, but it's deadly serious.

MAOIs block the breakdown of a substance called tiramine.

Tiramine is found in a lot of foods.

And tiramine acts like a sympathomimetic.

It triggers a massive release of norepinephrine.

Normally, the MAO enzyme in your gut breaks down tiramine before it can hurt you.

But if you are on an MAOI, that enzyme is blocked.

The tiramine gets into your bloodstream, triggers a norepinephrine flood, and boom.

Which causes...

A hypertensive crisis.

Your blood pressure shoots up to extremely high levels.

It can lead to stroke, intracranial hemorrhage, or death.

So the dietary restrictions have to be incredibly strict.

The text lists things like aged cheese.

Swiss blue cheddar.

Basically,

if the cheese is fancy and delicious, you probably can't eat it.

Cream, yogurt, coffee, chocolate.

Bananas, liver, pickled foods like sauerkraut, sausage, soy sauce, red wine, beer.

Anything with yeast.

That is a very long list of very common foods.

It basically rules out a charcuterie board and a pizza night.

It really does.

And it's not just food.

Over -the -counter cold medications containing finnelephrine or pseudoephedrine, those are vasoconstrictors, can also trigger this crisis.

Even herbal supplements like ginseng and ephedra.

The specific drugs mentioned are...

If you see these on a patient's chart, your radar needs to go up immediately regarding their diet and any other meds they're taking.

Absolutely.

Patient teaching here is literally life -saving.

You have to give them a printed list of foods and drugs to avoid.

You cannot rely on their memory.

Okay.

We are going to shift gears completely now.

We are leaving depression and moving to bipolar disorder and mood stabilizers.

The goal here is different.

We aren't just trying to elevate mood.

We're trying to stabilize it.

To treat bipolar affective disorder, reduce those wild mood swings, and control acute mania.

And the star of the show is lithium.

The gold standard.

Lithium is fascinating because it's a naturally occurring ion.

A simple element.

It's an antimenia drug.

It has a calming effect.

It controls that flight of ideas and hyperactivity you see in mania.

If the person stops taking lithium, the manic behavior often returns.

It's just wild to me that a simple element from the periodic table can control such complex human behavior.

How does it work?

The text says it alters ion transport in muscle and nerve cells.

It likely interferes with the sodium pump mechanism in neurons, which basically dampens the excitability of the cell.

It just palms everything down at a cellular level.

Pharmacokinetics seem critical here.

95 % absorbed through the GI tract.

And a half -life of 18 to 36 hours.

That's long.

But the most critical concept for lithium is its narrow therapeutic index.

This is so important, safe, critical.

What are the numbers?

You need to know these numbers cold.

The therapeutic range is 0 .8 to 1 .2 mEqL.

That is a tiny, tiny window.

It is.

The toxic range starts at just greater than 1 .5 mEqL.

And the lethal range is above 3 .5 mEqL.

So the difference between getting better and being in serious trouble is 0 .3 units.

That is razor thin.

Which is why monitoring is so intense.

Yeah.

By weekly blood levels initially, then every one to two months once they're on a maintenance dose, you cannot manage a patient on lithium without frequent labs.

Now here is where it gets really interesting and a bit tricky.

The sodium -lithium relationship.

This is the part that always trips students up.

This is the key physiological concept to grasp.

Lithium and sodium are chemically very similar.

They're like cousins on the periodic table.

The kidneys have a hard time telling them apart.

So they compete for excretion.

Here's the role.

Lithium tends to deplete sodium.

But more importantly, if the body is low on sodium for any reason, the kidney panics and holds on to anything that looks like sodium.

And that means it holds on to lithium.

So low sodium intake equals high lithium retention.

Correct.

Which leads to toxicity.

So the patient teaching is totally counterintuitive to what we usually tell people.

Maintain adequate sodium intake.

Do not go on a low -salt diet.

Do not go on crash diets.

If you stop eating salt, your lithium levels will skyrocket to dangerous levels.

And diuretics.

What about them?

That's a major warning.

Diuretics work by making you excrete sodium.

If you lose sodium, you retain lithium.

Tachylic levels can happen very fast.

You rarely mix diuretics and lithium.

So what are the side effects of lithium, assuming the levels are normal and therapeutic?

Dry mouth, thirst, polyuria.

That's excessive urination.

A metallic taste in the mouth, weight gain, and edema.

Especially in the hands and ankles.

It can be hard on the kidneys over the long term.

And teratogenicity.

Yes.

Hazardous during pregnancy.

The text notes it can cause cardiac defects in the fetus.

Before we move to the nursing process, the text mentions other mood stabilizers if lithium doesn't work.

Right.

If lithium isn't tolerated or isn't effective, we often use anticonvulsants like carbamazepine, valproic acid, or lamontrogen, or sometimes atypical antipsychotics like elanzapine.

But lithium remains the classic prototype.

Okay, let's bring all this home to the bedside.

Section 7.

The nursing process for antidepressants.

Let's start with assessment.

Baseline vitals are key.

Especially blood pressure for that orthostatic hypotension we talked about with the TCAs.

You need a baseline to know if it's changing.

And assessing for suicidal tendencies is the absolute priority.

Always.

First and foremost.

And checking for a history of glaucoma.

Because those anticholinergic drugs, the TCAs, are contraindicated.

They can increase intraocular pressure.

You also need to check for tardive dyskinesia and neuroelectric malignant syndrome, or NMS, which are rare but severe motor side effects.

Interventions.

Monitoring weight two, three times per week.

Why so often?

Weight gain is a common side effect of many of these drugs, and it really affects compliance and self -esteem.

Catching it early allows for intervention.

Safety monitoring for seizures.

Because, as we said, most antidepressants lower the seizure threshold.

And for MAOIs, constant monitoring for those hypertensive crisis symptoms.

Patient teaching is huge here.

Let's talk about the timeline.

You have to emphasize the one, two weeks, or even more, lag time.

Tell them, don't stop early.

It needs time to work.

And what about stopping the medication?

Never abruptly.

You risk withdrawal symptoms.

Nausea, dizziness, what patients describe as brain zaps.

It has to be tapered.

Alcohol.

Avoid it.

It increases the CNS depression.

It's a dangerous combination.

And the timing of doses.

A good rule of thumb.

Take TCAs at bedtime because they sedate you.

Take SSRIs in the morning because they can cause insomnia.

Perfect.

And finally, section eight.

The nursing process for lithium.

This is very specific.

Assessment here focuses heavily on neurologic status gate, reflexes, tremors, and renal function.

Remember, lithium is excreted by the kidneys and causes polyuria.

Urine output should be greater than 600 mL all a day.

When do we draw the blood levels for monitoring?

Timing is everything.

You draw the blood eight to 12 hours after the previous dose.

So immediately before the next dose is scheduled.

That gives you the trough level, the lowest point.

Interventions regarding fluids seem important.

Hugely.

Encourage fluid intake.

Two to three liters per day initially.

And tell them to increase it in hot weather or with exercise.

Dehydration concentrates the lithium and can cause toxicity.

And tremors.

You mentioned that.

You have to distinguish between fine motor tremors, which can be a normal side effect, and gloss motor tremors, which are a sign of toxicity.

Dietary teaching for lithium.

We hammered on salt.

What about caffeine?

Avoid caffeine.

Coffee, tea, cola.

Caffeine is a diuretic and it actually decreases lithium levels, which can aggravate the mania.

It works against the drug.

Finally, what are the toxicity signs a patient needs to report immediately?

Early signs.

Diarrhea, drowsiness, loss of appetite,

muscle weakness, slurred speech.

If you see those, the patient should hold the next dose and call the provider right away.

And late signs.

Late signs are an emergency.

Blurred vision, confusion, convulsions, unsteadiness.

It's a 911 call.

Wow.

That is a comprehensive run -through of a very complex topic.

It is.

We covered the full spectrum from the blues all the way to bipolar media.

To summarize, you really have to know your classes.

TCAs are dirty but effective.

SSRIs are clean and precise but can kill libido.

MARIs are a dietary minefield.

And lithium is all about that sodium balance in that razor -thin therapeutic window.

And through it all, the nurse is the safety barrier.

Monitoring the suicide risk, checking the blood levels, teaching about the cheese and the salt.

The mechanism really does make the decision -making intuitive.

If you understand that lithium competes with sodium, you instantly know why diuretics are a bad idea.

It all connects.

Exactly.

Knowledge applied is safety insured.

Well said.

Well, that brings us to the end of chapter 23.

This has been a heavy one but an incredibly important one.

Indeed it has.

Thank you so much for listening to this deep dive.

Good luck with your studies.

Goodbye and safe practice.